MOUNTAIN VIEW, Calif.,
April 22, 2014 /PRNewswire/ -- IRIDEX
Corporation (Nasdaq: IRIX) today announced that an educational
story based on its innovative MicroPulse™ technology for the
treatment of diabetic macular edema (DME) and age-related macular
degeneration (AMD), was recently featured on the Washington, D.C. edition of "American Health
Front," a health news program focused on advances in medical
techniques and technologies. Neal
Adams, M.D., a board-certified ophthalmologist and principal
at DC Retina in Silver Spring, MD,
presented an overview of the MicroPulse technology, a promising,
tissue-sparing laser therapy that allows the tissue to cool between
laser pulses, minimizing or preventing tissue damage.
Dr. Adams noted that certain key treatment risks are reduced or
eliminated with the use of MicroPulse, and patient comfort is
increased compared to conventional, continuous-wave laser
treatment.
"Patient care is about caring for the patient and
individualizing treatment, which is why I offer MicroPulse for my
AMD and diabetic patients," Dr. Adams said. "It doesn't burn or
damage the retina and the results are often excellent…It's really
impressive technology."
"Numerous recent studies have shown the effectiveness and
durability of the MicroPulse technology in treating DME, meaning it
should be considered a cost-effective alternative to the regimen of
drug treatments via eye injections currently in use," noted
William M. Moore, CEO of IRIDEX.
"Drugs injected directly into the eye have a role in treating
retinal diseases, but there are serious issues in terms of costs
and logistics due to the need for continuous injections for the
rest of one's life. This is just not a sustainable model in today's
value-based medicine world," Moore said. "MicroPulse offers
powerful advantages, in terms of durability, economics and
logistics for payors and patients."
To see the entire program, click on the following link:
https://www.dropbox.com/s/tnbasgtsdvhpxgs/Dr%20Adams%2C%20American%20Health%20Front%202014.mp4
The program can also be seen on YouTube at the following
link:
https://www.youtube.com/watch?v=6B59WmxzvXY
About MicroPulse Technology
MicroPulse is a tissue-sparing laser therapy that works by
electronically "chopping" the laser emission into trains of
microsecond pulses. This enhances the physician's ability to more
precisely control the laser effects on target tissues, offering the
potential for ocular treatment with less collateral effects than
conventional laser treatments.
About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader
in developing, manufacturing, and marketing innovative and
versatile laser-based medical systems, delivery devices and
consumable instrumentation for the ophthalmology market. We
maintain a deep commitment to the success of our customers, with
comprehensive technical, clinical, and service support programs.
IRIDEX is dedicated to a standard of excellence, offering superior
technology for superior results. IRIDEX products are sold in
the United States through a direct
sales force and internationally through a combination of a direct
sales force and a network of approximately 70 independent
distributors into over 100 countries. For further information,
visit the IRIDEX website at http://www.iridex.com/.
Safe Harbor Statement
This announcement contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Act of 1934, as
amended, relating to the Company's products and the markets for the
Company's products. These statements are not guarantees of
future performance and actual results may differ materially from
those described in these forward-looking statements as a result of
a number of factors. Please see a detailed description of
these and other risks contained in our Annual Report on Form 10-K
for the fiscal year ended December 28,
2013, and our Quarterly Reports on Form 10-Q for the fiscal
quarters ended March 30, 2013, June 29, 2013, and
September 28, 2013, each of which was filed with the
Securities and Exchange Commission. Forward-looking statements
contained in this announcement are made as of this date and will
not be updated.
Video - http://www.youtube.com/watch?v=6B59WmxzvXY
SOURCE IRIDEX Corporation